简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Micot Pharma
Shaanxi Micot Pharmaceutical Technology Co., Ltd (02335.HK): Phase II Clinical Study of Dual-Function Antithrombotic Candidate MT1002 for Anticoagulation in Haemodialysis Completes First Patient Enrolment
Tags：
Micot Pharma
02335.HK
Clinical Trial
2026-07-09
Micot Pharma-B (02335.HK) Launches IPO: Max Offer Price at HK$21.0, Entry Fee Around HK$4,242 per Lot
Tags：
Micot Pharma
02335.HK
IPO
2026-06-15
Micot Pharma Passes HKEX Listing Hearing, Lead Candidate MT1013 in Phase III Clinical Trial
Tags：
Micot Pharma
IPO
pass the listing hearing
2026-06-05
Featured News
Finance
BILLION INDUSTRIAL HOLDINGS(02299.HK): Positive Profit Forecast, Interim Profit Attributable to Owners Expected to Surge by No Less Than 160%
Finance
Shenzhen Expressway Corporation Limited (00548.HK): Completes Issuance of Phase 2 Medium-Term Notes of 2026 in the Amount of RMB1 Billion
Finance
KINGDOM HOLDINGS (00528.HK): Expects to Swing to Profit in Interim Period with Net Profit of No Less Than RMB100 Million
Finance
GDS Global Secures New Contracts Worth Approximately S$6 Million in Singapore
Finance
FRASERS CENTREPOINT TRUST: Consortium Wins Tender for Mixed-Use Site at Bayshore Drive; Retail Mall Development Cost Estimated at S$613 Million
Finance
HS Optimus Holdings Completes Acquisition of 30% Stake in Medicorp Sdn Bhd
Research
HKIC-Backed Moonshot AI Releases Kimi K3, the World's Largest Open-Source Model by Parameter Scale, Claiming Top Spot on International Leaderboards
ETF
Samsung NYSE FANG+ ETF(02814.HK) Rises 0.96% Intraday with Average Trading Price of HK$48.336
ETF
CMS Hang Seng Tech Index ETF(03423.HK) Rises 1.35% Intraday, NAV Per Unit at HK$8.522
ETF
Chinaamc CSI 300 Index ETF(03188.HK) Rises 2.26% Intraday with AUM of HK$18.18 Billion
Scan QR Code
Download App
